• CGP 55845 Hydrochloride: Advancing GABAB Antagonist Assays

  2026-05-27

  CGP 55845 hydrochloride empowers researchers to dissect GABAB receptor signaling with unprecedented precision, streamlining in vitro workflows for synaptic transmission and neurotransmitter modulation. Its selectivity and reliability set a new benchmark for astrocyte-neuron research and troubleshooting complex neural assays.

• Dissecting In Vitro Drug Response Metrics in Cancer Research

  2026-05-27

  Schwartz's doctoral research redefines how anti-cancer drug responses are measured in vitro by distinguishing between relative viability and fractional viability metrics. This approach sharpens the interpretation of apoptosis inhibitor research and provides a clearer framework for evaluating agents such as survivin inhibitors in translational oncology.

• PCI-32765 (Ibrutinib): Applied Workflows in B-Cell Research

  2026-05-26

  PCI-32765 (Ibrutinib) empowers researchers to dissect B-cell receptor signaling with unmatched selectivity and ease. This guide covers reproducible workflows, troubleshooting, and how recent insights from ATRX-deficient models expand Ibrutinib’s value in translational bench studies.

• Propranolol: Mechanistic Advances and Translational Research

  2026-05-26

  This thought-leadership article explores the multifaceted mechanisms of propranolol as a non-selective β-adrenergic receptor blocker, synthesizing emerging insights in cardiovascular, metabolic, and neuropsychiatric research. Designed for translational researchers, it bridges biological rationale, experimental best practices, and competitive landscape analysis with a forward-looking outlook—anchored by robust product intelligence from APExBIO and cutting-edge literature.

• Oncolytic rMeV-Hu191 Induces Apoptosis in Breast Cancer Mode

  2026-05-25

  Zheng et al. present a comprehensive analysis of the recombinant measles virus strain Hu191 (rMeV-Hu191) as an oncolytic agent for breast cancer, revealing multifaceted antitumor effects via apoptosis induction, proliferation inhibition, and cellular senescence. The study's mechanistic and in vivo results suggest rMeV-Hu191 may offer a promising alternative for resistant breast cancers, with implications for future apoptosis pathway research.

• Mitoxantrone Targets ERα DBD-LBD Interface to Overcome Resis

  2026-05-25

  The reference study identifies a novel allosteric inhibition mechanism for estrogen receptor alpha (ERα) via mitoxantrone binding at the DBD-LBD interface, leading to rapid proteasomal degradation and disruption of receptor function. This mechanism is effective against both wild-type and therapy-resistant ERα mutants, providing a new strategy to circumvent endocrine resistance in breast cancer models.

• Concanamycin A: Precision V-ATPase Inhibition in Cancer Biol

  2026-05-24

  Discover how Concanamycin A, a potent V-type H+-ATPase inhibitor, enables targeted disruption of tumor cell survival and invasiveness. This article uniquely explores its mechanistic selectivity, advanced research uses, and new insights from sphingolipid regulation.

• Irinotecan (CPT-11): Workflow Enhancements in Colorectal Can

  2026-05-23

  Harness Irinotecan’s potent topoisomerase I inhibition and proven efficacy for robust DNA damage, apoptosis, and tumor suppression assays. Discover protocol refinements, troubleshooting strategies, and advanced applications that elevate colorectal cancer research with APExBIO’s trusted reagent.

• Anti-HMGB1 Rabbit Monoclonal Antibody: Protocol and QC Guida

  2026-05-22

  The Anti-HMGB1 Rabbit Monoclonal Antibody (SKU MA3057) is designed for reliable detection of HMGB1 protein in human, mouse, and rat research samples across Western blot, immunohistochemistry, and flow cytometry. This reagent supports chromatin protein studies but is not validated for diagnostic or therapeutic use.

• Berberine Hydrochloride Expands Tuft Cells to Counter Bone L

  2026-05-22

  A recent study demonstrates that berberine hydrochloride mitigates estrogen deficiency-induced bone loss by promoting intestinal tuft cell expansion through butyrate-GPR41 signaling. This discovery establishes a mechanistic link between the gut-bone axis and osteoimmunity, highlighting new opportunities for postmenopausal osteoporosis research.

• hly Gene Deletion Impairs Biofilm and Antibiotic Resistance

  2026-05-21

  This study investigates the functional role of the hly gene in Listeria monocytogenes, focusing on its impact on biofilm formation, virulence regulation, and antibiotic sensitivity. The findings reveal that hly deletion significantly compromises biofilm architecture and increases susceptibility to antibiotics, with implications for food safety and pathogen control.

• Cy5 Hydrazide: Advancing Precision in Translational Nanobiol

  2026-05-21

  This article explores the mechanistic utility and translational potential of Cy5 hydrazide (non-sulfonated) as a carbonyl-reactive fluorescent dye, elevating biomolecule tracking and protein carbonylation labeling in oxidative stress and food-grade nanoparticle systems. Integrating recent advances in facilitated self-assembly nanotechnology, we deliver strategic guidance for researchers at the interface of analytical biochemistry and next-generation nutraceutical delivery. APExBIO’s Cy5 hydrazide is positioned as a robust alternative to Alexa Fluor 647, with unique workflow insights and protocol parameters for optimal implementation.

• Abiraterone Acetate: CYP17 Inhibitor Workflows in Prostate C

  2026-05-20

  Unlock the full translational impact of Abiraterone acetate as a potent CYP17 inhibitor in cutting-edge prostate cancer research. This guide details optimized workflows, troubleshooting strategies, and highlights from recent advances in 3D patient-derived models, setting the standard for rigorous experimental design.

• HyperScribe™ T7 High Yield Cy5 RNA Labeling Kit: Atomic Insi

  2026-05-20

  The HyperScribe T7 High Yield Cy5 RNA Labeling Kit enables robust, high-yield fluorescent RNA probe synthesis through in vitro transcription using Cy5-UTP. This kit provides customizable probe labeling for sensitive detection in in situ and Northern blot hybridization, establishing itself as a standard in research workflows.

• (+)-Bicuculline: Technical Use and Protocol Parameters

  2026-05-19

  (+)-Bicuculline is a classical GABAA receptor antagonist widely utilized in neuroscience research to dissect inhibitory neurotransmission and modulate synaptic NMDA receptor signaling. It is not intended for clinical, diagnostic, or therapeutic use, and rigorous attention to solubility and storage is essential for experimental reproducibility.

15489 records 7/1033 page Previous Next First page 上5页 678910 下5页 Last page